{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T22:28:34Z","timestamp":1768688914323,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T00:00:00Z","timestamp":1672444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T00:00:00Z","timestamp":1672444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10147-022-02282-x","type":"journal-article","created":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T03:02:43Z","timestamp":1672455763000},"page":"331-340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Current methods of preventing infectious disease and managing febrile neutropenia in childhood cancer patients: a nationwide survey in Japan"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1515-5219","authenticated-orcid":false,"given":"Shinya","family":"Osone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirozumi","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Shinkoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Kakazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuki","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,31]]},"reference":[{"key":"2282_CR1","unstructured":"Japanese Society of Pediatric Hematology\/Oncology (2011) Supportive care (in Japanese). In: Japanese Society of Pediatric Hematology\/Oncology (ed) A practical guideline for pediatric leukemia and lymphoma, 2nd edn. Kanehara, Tokyo, pp95\u2013121."},{"key":"2282_CR2","unstructured":"Japanese Society of Pediatric Hematology\/Oncology (2016) Supportive care (in Japanese). In: Japanese Society of Pediatric Hematology\/Oncology (ed) A practical guideline for pediatric leukemia and lymphoma, 3rd edn. Kanehara, Tokyo, pp121\u2013180."},{"key":"2282_CR3","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1200\/JCO.2008.18.7948","volume":"27","author":"I Tsukimoto","year":"2009","unstructured":"Tsukimoto I, Tawa A, Horibe K et al (2009) Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group. J Clin Oncol 27:4007\u20134013","journal-title":"J Clin Oncol"},{"key":"2282_CR4","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1182\/blood.2019004741","volume":"136","author":"D Tomizawa","year":"2020","unstructured":"Tomizawa D, Miyamura T, Imamura T et al (2020) A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial. Blood 136:1813\u20131823","journal-title":"Blood"},{"key":"2282_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/MPH.0000000000001926","volume":"43","author":"S Nakagawa","year":"2021","unstructured":"Nakagawa S, Kato M, Imamura T et al (2021) In-hospital management might reduce induction deaths in pediatric patients with acute lymphoblastic leukemia: results from a Japanese cohort. J Pediatr Hematol Oncol 43:39\u201346","journal-title":"J Pediatr Hematol Oncol"},{"key":"2282_CR6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR III, Denning DW et al (2016) Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 63:e1-60","journal-title":"Clin Infect Dis"},{"key":"2282_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jhin.2017.07.021","volume":"97","author":"A Katayama Katsuse","year":"2017","unstructured":"Katayama Katsuse A, Takahashi H, Yoshizawa S et al (2017) Public health and healthcare-associated risk of electric, warm-water bidet toilets. J Hosp Infect 97:296\u2013300","journal-title":"J Hosp Infect"},{"key":"2282_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4058\/jsei.30.317","volume":"30","author":"M Hayashi","year":"2015","unstructured":"Hayashi M, Nakai I, Fujiwara H et al (2015) Transmission of drug resistant Pseudomonas aeruginosa in the hematology unit associated with toilet seats with bidet functions (in Japanese). Jpn J Infect Prevent Control 30:317\u2013324","journal-title":"Jpn J Infect Prevent Control"},{"key":"2282_CR9","unstructured":"CDC (2007) Guidelines for isolation precautions: preventing transmission of infectious agents in healthcare settings. https:\/\/www.cdc.gov\/infectioncontrol\/guidelines\/isolation\/index.html. Accessed Dec 2021"},{"key":"2282_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnsa.2020.100013","volume":"3","author":"M Abboah-Offei","year":"2021","unstructured":"Abboah-Offei M, Salifu Y, Adewale B et al (2021) A rapid review of the use of face mask in preventing the spread of COVID-19. Int J Nurs Stud Adv 3:100013","journal-title":"Int J Nurs Stud Adv"},{"issue":"Suppl 1","key":"2282_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1469-0691.12427","volume":"20","author":"E Tacconelli","year":"2014","unstructured":"Tacconelli E, Cataldo MA, Dancer SJ et al (2014) ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 20(Suppl 1):1\u201355","journal-title":"Clin Microbiol Infect"},{"key":"2282_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/INF.0000000000002273","volume":"38","author":"Y Aizawa","year":"2019","unstructured":"Aizawa Y, Shoji T, Ito K et al (2019) Multidrug-resistant Gram-negative bacterial bloodstream infections in children\u2019s hospitals in Japan, 2010\u20132017. Pediatr Infect Dis 38:653\u2013659","journal-title":"Pediatr Infect Dis"},{"key":"2282_CR13","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/jac\/dkw157","volume":"71","author":"J Maertens","year":"2016","unstructured":"Maertens J, Cesaro S, Maschmeyer G et al (2016) ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother 71:2397\u20132404","journal-title":"J Antimicrob Chemother"},{"key":"2282_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41408-020-0287-4","volume":"10","author":"D Hasegawa","year":"2020","unstructured":"Hasegawa D, Imamura T, Yumura-Yagi K et al (2020) Risk-adjusted therapy for pediatric non-T cell ALL improves outcomes for standard risk patients: results of JACLS ALL-02. Blood Cancer J 10:23","journal-title":"Blood Cancer J"},{"key":"2282_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/cid\/ciz1082","volume":"71","author":"T Lehrnbecher","year":"2020","unstructured":"Lehrnbecher T, Fisher BT, Phillips B et al (2020) Guideline for antibacterial prophylaxis administration in pediatric cancer and hematopoietic stem cell transplantation. Clin Infect Dis 71:226\u2013236","journal-title":"Clin Infect Dis"},{"key":"2282_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/MPH.0000000000001415","volume":"41","author":"AE Holmes","year":"2019","unstructured":"Holmes AE, Friedman DL, Connelly JA et al (2019) Impact of IgG monitoring and IVIG supplementation on the frequency of febrile illnesses in pediatric acute lymphoblastic leukemia patients undergoing maintenance chemotherapy. J Pediatr Hematol Oncol 41:423\u2013428","journal-title":"J Pediatr Hematol Oncol"},{"key":"2282_CR17","unstructured":"National Comprehensive Cancer Network (2021). NCCN Guidelines version 1.2021. Prevention and treatment of cancer-related infections. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=3&id=1457. Accessed Mar 2022"},{"key":"2282_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s10156-010-0121-1","volume":"17","author":"M Mori","year":"2011","unstructured":"Mori M, Kawashima H, Nakamura H et al (2011) Nationwide survey of severe respiratory syncytial virus infection in children who do not meet indications for palivizumab in Japan. J Infect Chemother 17:254\u2013263","journal-title":"J Infect Chemother"},{"key":"2282_CR19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s12185-015-1890-1","volume":"102","author":"M Hatanaka","year":"2015","unstructured":"Hatanaka M, Miyamura T, Koh K et al (2015) Respiratory syncytial virus infection in infants with acute leukemia: a retrospective survey of the Japanese Pediatric Leukemia\/Lymphoma Study Group. Int J Hematol 102:697\u2013701","journal-title":"Int J Hematol"},{"key":"2282_CR20","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1097\/INF.0000000000000392","volume":"33","author":"M Mori","year":"2014","unstructured":"Mori M, Onodera M, Morimoto A et al (2014) Palivizumab use in Japanese infants and children with immunocompromised conditions. Pediatr Infect Dis J 33:1183\u20131185","journal-title":"Pediatr Infect Dis J"},{"key":"2282_CR21","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","volume":"35","author":"T Lehrnbecher","year":"2017","unstructured":"Lehrnbecher T, Robinson P, Fisher B et al (2017) Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol 35:2082\u20132094","journal-title":"J Clin Oncol"},{"key":"2282_CR22","doi-asserted-by":"crossref","unstructured":"Lehrnbecher T, Averbuch D, Castagnola E, et al. (2021) 8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation. Lancet Oncol 22: e270-e280","DOI":"10.1016\/S1470-2045(20)30725-7"},{"key":"2282_CR23","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1200\/JCO.2015.62.3488","volume":"33","author":"TJ Smith","year":"2015","unstructured":"Smith TJ, Bohlke K, Lyman GH et al (2015) Recommendations for the use of WBC growth factors: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 33:3199\u20133212","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02282-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-022-02282-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02282-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:37:00Z","timestamp":1744209420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-022-02282-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,31]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["2282"],"URL":"https:\/\/doi.org\/10.1007\/s10147-022-02282-x","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,31]]},"assertion":[{"value":"13 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No author has any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}